Predict your next investment

BioLight Life Sciences company logo
HEALTHCARE | Medical Devices & Equipment / Other Medical Devices
bio-light.co.il

See what CB Insights has to offer

About BioLight Life Sciences

Bio-Light is an ophthalmic company focused on the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD. The company is publicly traded on the Tel-Aviv Stock Exchange (BOLT).Bio-Light was founded in 2005 by a group of professionals highly experienced in all aspects of the Israeli life science investment environment. This team provides each Bio-Light subsidiary with ongoing support, resources and expertise in science, regulation, business development, and intellectual property by Israel's leading intellectual property law firm, Ehrlich and Partners, is fully owned by Bio-Light's co-founder, Dr. Gal Ehrlich.Each Bio-Light subsidiary company was carefully chosen by the founders using strict criteria for investment. Every project that Bio-Light took on was required to have advanced beyond the proof-of-concept stage to a later stage of development, and it was mandatory that each company possess both solid intellectual property and a world-class scientific team. A controlling position was sought in all of the four subsidiaries and today Bio-Light possesses 86-100% equity in each one.

BioLight Life Sciences Headquarter Location

Tel Aviv,

Israel

+972-73-2753400

Latest BioLight Life Sciences News

BioLight invests in $1m in AEYE Health

Mar 21, 2021

BioLight invests in $1m in AEYE Health BioLight Life Sciences has an option to invest a further $1.5 million in AEYE Health, a developer of AI-based ophthalmic diagnostics technology. Israeli ophthalmic company BioLight Life Sciences Ltd. (TASE: BOLT) reports that it has completed an investment of $1 million in AEYE Health Inc. in exchange for 4.8% of its shares. Among other investors in the round are Naska Medical, a life sciences fund owned by Samy Katsav's SK Group , Israeli investor group Club 100 plus, and prominent US-based ophthalmologist Prof. Sean Ianchulev. BioLight has an option to invest a further $1.5 million in AEYE Health, in accordance with progress in its trial in the US and US Food and Drug Administration (FDA) approval. Exercise of the option will bring the current round to $5.8 million and BioLight's holding to 10% of AEYE Health, or 9.5% fully diluted. AEYE Health, which has offices in New York and Tel Aviv, is a developer of AI-based solutions for rapid diagnosis of diseases that endanger vision. Its product for automatic detection of complications of diabetes in the retina such as diabetic retinopathy and diabetic macular edema, which are the greatest causes of blindness among working-age people, is in the advanced stages of trials in the US for obtaining FDA approval. "AEYE Health's technology provides a rapid response for tens of millions of patients. The investment in it reflects our expansion in the growing field of digital health and out preference for companies close to the revenue stage," said BioLight CEO Yaacov Michlin. Published by Globes, Israel business news - en.globes.co.il - on March 21, 2021 © Copyright of Globes Publisher Itonut (1983) Ltd. 2021

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioLight Life Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioLight Life Sciences is included in 2 Expert Collections, including CES 2018 Exhibitors.

C

CES 2018 Exhibitors

760 items

Companies that will be exhibiting at CES 2018

C

Conference Exhibitors

4,993 items

BioLight Life Sciences Patents

BioLight Life Sciences has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/26/2013

Sensors, Diodes, Spectroscopy, Radar, Optical devices

Application

Application Date

4/26/2013

Grant Date

Title

Related Topics

Sensors, Diodes, Spectroscopy, Radar, Optical devices

Status

Application

BioLight Life Sciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BioLight Life Sciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.